A small group has gathered at the World Health Organization in Geneva to discuss a controversy over experiments that generated genetically altered viruses. After the meeting, which ends Friday, the WHO will announce what happened behind closed doors.
The Food and Drug Administration will take a second look at a weight-loss drug it rejected in 2010. The decision to review Qnexa comes as the agency is rethinking how it judges weight-loss drugs. Though obesity is at epidemic levels, the FDA hasn't approved any new weight-loss medicines since 1999.
The good news for doctors: a nearly 28 percent cut in Medicare reimbursements likely won't take effect March 1. The bad news: the deal isn't permanent and a cut could be about 32 percent next year. That's leaving doctors who treat medicare patients in a continued state of uncertainty.
The current controversy over insurance coverage of contraceptives is the latest chapter in the long and often bitter history of conflicts between the right to follow one's conscience and the demands of society.
Congress appears ready to once again defer a scheduled cut in pay for doctors who treat Medicare patients. This time the cut would otherwise be just shy of 30 percent. But at the end of the year, doctors will once again be at the mercy of lawmakers and some say they're growing weary of the annual uncertainty.
When you give to WAMU, your tax-deductible membership gift helps make possible award-winning programs such as Morning Edition, All Things Considered, The Diane Rehm Show, The Kojo Nnamdi Show, and other favorites.